Zuga Matt — SEC Form 4 filings
SEC reporting owner CIK 1790214. 12 Form 4 filings on record with FilingPulse; latest filed 2026-01-23.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-01-08 to 2026-01-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 420,000 shares, $1,050,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 11 legs across 6 filings — 76,696 shares, $146,259 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: purchase of 420,000 shares @ $2.50 ($1,050,000) in ELUTIA INC., filed 2025-03-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ELUTIA INC. (ELUT) | Director, 10% owner | 5 | 1 leg · 420,000 sh · $1,050,000 | — | 6 |
| Acumen Pharmaceuticals, Inc. (ABOS) | CFO & Chief Business Officer | 7 | — | 11 legs · 76,696 sh · $146,259 | 4 |
Form 4 filings — Zuga Matt
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-23 | 4 | Acumen Pharmaceuticals, Inc. (ABOS) | Sale (S): 2,473 @ $1.81 · Sale (S): 1,687 @ $1.86 | EDGAR |
| 2026-01-21 | 4 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/award (A): 99,133 @ $0 · Grant/award (A): 148,700 (derivative) @ $0 | EDGAR |
| 2026-01-12 | 4 | Acumen Pharmaceuticals, Inc. (ABOS) | Sale (S): 6,888 @ $1.82 | EDGAR |
| 2026-01-07 | 4 | Acumen Pharmaceuticals, Inc. (ABOS) | Sale (S): 4,000 @ $1.96 · Sale (S): 5,100 @ $1.97 · Sale (S): 4,105 @ $2.00 · Sale (S): 1,700 @ $1.99 | EDGAR |
| 2025-06-02 | 4 | ELUTIA INC. (ELUT) | Grant/award (A): 60,339 (derivative) @ $0 | EDGAR |
| 2025-03-13 | 4 | ELUTIA INC. (ELUT) jointly with HighCape Capital, L.P., RAKIN KEVIN, HighCape Partners GP, LLC, HighCape Partners GP, L.P., HIGHCAPE PARTNERS, L.P., HIGHCAPE PARTNERS QP, L.P., HighCape Capital, LLC, HighCape Partners GP II, L.P., HighCape Co-Investment Vehicle I, LLC | Purchase (P): 420,000 @ $2.50 | EDGAR |
| 2025-01-23 | 4 | Acumen Pharmaceuticals, Inc. (ABOS) | Sale (S): 4,364 @ $1.60 · Sale (S): 28,902 @ $1.72 | EDGAR |
| 2025-01-07 | 4 | Acumen Pharmaceuticals, Inc. (ABOS) | Sale (S): 13,235 @ $1.84 · Grant/award (A): 66,800 @ $0 · Grant/award (A): 100,300 (derivative) @ $0 | EDGAR |
| 2024-08-01 | 4 | ELUTIA INC. (ELUT) jointly with HighCape Capital, L.P., RAKIN KEVIN, HighCape Partners GP, LLC, HighCape Partners GP, L.P., HIGHCAPE PARTNERS, L.P., HIGHCAPE PARTNERS QP, L.P., HighCape Partners QP II, L.P., HighCape Partners GP II, LLC, HighCape Partners GP II, L.P. | Option exercise/expiry (X): 2,101,577 @ $1.43 · Option exercise/expiry (X): 2,101,577 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | ELUTIA INC. (ELUT) | Grant/award (A): 31,835 (derivative) @ $0 | EDGAR |
| 2024-01-19 | 4 | Acumen Pharmaceuticals, Inc. (ABOS) | Sale (S): 4,242 @ $3.71 | EDGAR |
| 2024-01-08 | 4 | ELUTIA INC. (ELUT) jointly with HighCape Capital, L.P., RAKIN KEVIN, HighCape Partners GP, LLC, HighCape Partners GP, L.P., HIGHCAPE PARTNERS, L.P., HIGHCAPE PARTNERS QP, L.P., HighCape Partners QP II, L.P., HighCape Partners GP II, LLC, HighCape Partners GP II, L.P. | Other (J): 1,436,077 · Other (J): 2,154,116 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-04 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1790214 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →